Does Anyone Care About Gilead's Beat, Guidance Boost?

By: via Benzinga
In a report published Friday, Cowen and Company analysts maintained an Outperform rating on Gilead Sciences (NASDAQ: GILD), with a ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.